Current rheumatology reviews最新文献_第3页

Efficiency of Glucosamine in Treating Temporomandibular Joint Osteoarthritis: A Meta-Analytic Umbrella Review. 葡萄糖胺治疗颞下颌关节骨关节炎的效果：系统回顾

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971309907240527105306

Sasidharan Sivakumar, Prabhakaran Prem Kumar, Palindla Lakshmi Prasanna, Gowardhan Sivakumar, Sesuraj Balasamy, Ashok K Sundramoorthy

{"title":"Efficiency of Glucosamine in Treating Temporomandibular Joint Osteoarthritis: A Meta-Analytic Umbrella Review.","authors":"Sasidharan Sivakumar, Prabhakaran Prem Kumar, Palindla Lakshmi Prasanna, Gowardhan Sivakumar, Sesuraj Balasamy, Ashok K Sundramoorthy","doi":"10.2174/0115733971309907240527105306","DOIUrl":"10.2174/0115733971309907240527105306","url":null,"abstract":"Background: Temporomandibular joint osteoarthritis (TMJ OA) is a chronic disease that is a consequence of undue occlusal forces and is characterized by irreversible damage to the articular surfaces. Symptomatic slow-acting so-called nutraceutical drugs have been proposed as a treatment for osteoarthritis in comparison to non-steroidal anti-inflammatory drugs (NSAIDs). Oral glucosamine and chondroitin, slow-acting drugs, have been found to reduce pain and increase mouth opening in patients with TMJ OA. However, there is limited scientific evidence to confirm their clinical effectiveness.Aim: This systematic review was conducted to bolster the evidence supporting the assessment of the efficacy of glucosamine in the context of temporomandibular joint osteoarthritis (TMJ OA).Methodology: This review identified four review articles from databases like Medline (via PubMed), Web of Science, Scopus, and EMBASE till September 2023 after screening at the title, abstract, and full-text level. They were assessed for risk of bias with the JBI risk of bias assessment tool.Results: This review with meta-analysis focused on pooled estimate mean differences, revealing non-significant but discernible effects of glucosamine on maximum mouth opening (SMD = 0.288, p = 0.15) and pain reduction (SMD = 0.217, p = 0.476) in TMJ-related disorders.Conclusion: Compared to control groups with ibuprofen and tramadol, glucosamine showed slightly more favourable outcomes. However, the variability in methodology and study characteristics warrants further longitudinal studies to confirm its efficacy.","PeriodicalId":11188,"journal":{"name":"Current rheumatology reviews","volume":" ","pages":"194-201"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Methotrexate - Safe Backbone for the Treatment of Rheumatoid Arthritis. 甲氨蝶呤--治疗类风湿性关节炎的安全支柱。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971317122240626053727

Marco Krasselt

引用次数: 0

Rituximab Induced Flare of Psoriatic Arthritis in a Patient with Devic's Syndrome: A Case Report. 利妥昔单抗诱发德维奇综合征患者银屑病关节炎复发：病例报告。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971275981240221062257

Sofia Audrey B Gonzales, Kiana Mortezaei, Daniel G Arkfeld

{"title":"Rituximab Induced Flare of Psoriatic Arthritis in a Patient with Devic's Syndrome: A Case Report.","authors":"Sofia Audrey B Gonzales, Kiana Mortezaei, Daniel G Arkfeld","doi":"10.2174/0115733971275981240221062257","DOIUrl":"10.2174/0115733971275981240221062257","url":null,"abstract":"Introduction/background: Devic's syndrome is a rare autoimmune disorder that occurs when the body's immune system damages and mistakenly attacks the optic nerves and spinal cord, leading to numerous neurological symptoms such as inflammation, weakness, numbness, and vision problems. Rituximab has mainly been utilized as an immunosuppressive therapy for patients with Devic's syndrome. Although evidence has shown that rituximab is efficient and well tolerated in treating patients with Devic's syndrome, there is the possibility of rituximab exacerbating severe psoriasis and psoriatic arthritis flare.Case presentation: In this paper, we describe a case of a 58-year-old female with Devic's syndrome, blindness, and neurological involvement who responded exceptionally well to rituximab but developed a severe flare of psoriatic arthritis. After withdrawing from the use of rituximab, her psoriatic arthritis symptoms had resolved. However, she did have another episode of blindness, and rituximab was started once again. Although her vision improved, her psoriatic arthritis symptoms had reoccurred. The patient was switched to eculizumab and ustekinumab, which controlled both her psoriatic arthritis and Devic's syndrome.Conclusion: Very few reports have identified rituximab to induce a flare-up of psoriatic arthritis, raising uncertainty regarding its potential effects on psoriatic symptoms. The precise mechanism underlying the exacerbation of psoriatic arthritis by rituximab remains uncertain. This case report highlights that rituximab can worsen psoriasis and psoriatic arthritis, and that the complexities of Devic's syndrome may require medication adjustments.","PeriodicalId":11188,"journal":{"name":"Current rheumatology reviews","volume":" ","pages":"109-112"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139995852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Uncommon Coexistence of Systemic Lupus Erythematosus and Psoriatic Arthritis: A Case-Based Review. 系统性红斑狼疮与银屑病关节炎并存的罕见现象：基于病例的综述。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971294744240530051404

Aliki I Venetsanopoulou, Ioanna Katsigianni, Elpida Skouvaklidou, Periklis Vounotrypidis, Paraskevi V Voulgari

{"title":"Uncommon Coexistence of Systemic Lupus Erythematosus and Psoriatic Arthritis: A Case-Based Review.","authors":"Aliki I Venetsanopoulou, Ioanna Katsigianni, Elpida Skouvaklidou, Periklis Vounotrypidis, Paraskevi V Voulgari","doi":"10.2174/0115733971294744240530051404","DOIUrl":"10.2174/0115733971294744240530051404","url":null,"abstract":"Cases of systemic lupus erythematosus (SLE) following psoriatic arthritis (PsA) or vice versa are uncommon. Due to the complexity of autoimmune diseases and the rarity of such cases, comprehensive global data on the co-occurrence of these conditions are limited. Moreover, the pathophysiology concerning the coexistence of SLE and PsA has yet to be fully understood. Interestingly, the progression of both diseases appears to be significantly influenced by the key interleukin (IL) 17, particularly IL-17A. Here, we report 7 cases of SLE and PsA coexistence. In 5 of these cases, PsA occurred before the development of SLE, while in the remaining 2 cases, SLE was diagnosed before PsA. The PsA was characterized mainly by peripheral arthritis without any axial involvement, while the manifestations of SLE varied, with 3 developing systematic severe manifestations. Therapeutic challenges were posed in all cases, as treating one condition could worsen the other. Finally, we review the literature providing the current knowledge on the coexistence of these conditions. Overall, all reported cases emphasize the importance of personalized treatment and careful monitoring for patients with both SLE and PsA.","PeriodicalId":11188,"journal":{"name":"Current rheumatology reviews","volume":" ","pages":"116-122"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141317069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Anti-Inflammatory and Anti-Arthritis Activity of Quercetin: A Comprehensive Review. 槲皮素的抗炎和抗关节炎活性：全面综述。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971280645240415101912

Shikha Chaudhary, Shaweta Sharma, Shivkanya Fuloria, Pramod Kumar Sharma

{"title":"Anti-Inflammatory and Anti-Arthritis Activity of Quercetin: A Comprehensive Review.","authors":"Shikha Chaudhary, Shaweta Sharma, Shivkanya Fuloria, Pramod Kumar Sharma","doi":"10.2174/0115733971280645240415101912","DOIUrl":"10.2174/0115733971280645240415101912","url":null,"abstract":"This comprehensive exploration delves into the multifaceted attributes of quercetin, a flavonoid with extensive health-promoting potential. The review navigates through its fundamental properties, encompassing its chemical structure, classification as a flavonoid, and its natural prevalence in various sources. Addressing solubility, stability, and bioavailability challenges, the investigation delves into innovative isolation techniques, including solvent extraction, solid-phase extraction, natural deep eutectic solvents, supercritical fluid extraction, microwave-assisted extraction, column chromatography, and high-performance thin-layer chromatography. Transitioning into pharmacological implications, the study unveils quercetin's roles in anti-inflammatory pathways, antioxidant effects, and immune modulation, reflecting its versatile significance in health management. The review highlights its impact on wound healing processes and its potential to mitigate arthritis, elucidating its holistic contributions. Culminating in an exploration of recent studies, the analysis underscores quercetin's remarkable anti-inflammatory and anti-arthritis activities, reflecting its substantial potential across various ailments. The review concludes by projecting future trajectories, emphasizing prospects for an advanced understanding of quercetin's mechanisms, sustainable extraction techniques, clinical integration, and exploration of synergistic combinations. Collectively, this review investigation underscores quercetin's dynamic role at the intersection of natural compounds and medicinal applications, offering profound implications for well- being and health enhancement.","PeriodicalId":11188,"journal":{"name":"Current rheumatology reviews","volume":" ","pages":"144-159"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Impact of Nicotine Use on Osteoarthritis. 尼古丁的使用对骨关节炎的影响。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971270925240318080227

Georges El Hasbani, Ali S M Jawad, Imad Uthman, Joseph E Nassar

引用次数: 0

Maxillary Sinusitis with Aspergillus Infection Mimicking Giant Cell Arteritis. 模仿巨细胞动脉炎的曲霉菌感染上颌窦炎

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971289010240322075304

Georges El Hasbani, Zi Ying Li, Joanne Szczygiel Cunha

引用次数: 0

A Review of Connecting Bioinformatic Techniques to Rheumatoid Arthritis and its Associated Comorbidities. 将生物信息学技术与类风湿关节炎及其相关并发症联系起来的综述。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971302188240515075547

Yeswanth Ranganathan, Pritam Ramesh Kumar, Sudhakar Gandhi Paramasivam, Ravi Shankar Krishnan

{"title":"A Review of Connecting Bioinformatic Techniques to Rheumatoid Arthritis and its Associated Comorbidities.","authors":"Yeswanth Ranganathan, Pritam Ramesh Kumar, Sudhakar Gandhi Paramasivam, Ravi Shankar Krishnan","doi":"10.2174/0115733971302188240515075547","DOIUrl":"10.2174/0115733971302188240515075547","url":null,"abstract":"Rheumatoid Arthritis (RA) is a progressive autoimmune condition inflicting serious threats to people's life and health by causing severe pain and joint destruction. It affects not only bones and joints but also causes comorbid conditions and shortens the lifetime. The interactions and synergistic effects of comorbid disease with RA are not yet well studied. Hence, understanding how these conditions will collectively affect the progression and outcome of RA is the current area of research. Identification of RA and comorbidities associated with target genes may uncover diagnosis and treatment methodologies. This review is to provide an overview of the interlinking approach of Rheumatoid Arthritis with its comorbid conditions and its systemic complications using bioinformatic techniques which would be useful to identify the genes and pathways that are in common for both RA and comorbid diseases. It would also emphasize the significance of bioinformatics in comparing the pathological features of RA and comorbid diseases. With the help of bioinformatics, valuable insights into the mechanism underlying Rheumatoid arthritis and comorbid diseases would be better understood.","PeriodicalId":11188,"journal":{"name":"Current rheumatology reviews","volume":" ","pages":"25-36"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mixed Connective Tissue Disease (MCTD) in a Girl with Lower Extremities Edema: A Brief Report. 一名下肢水肿女孩的混合结缔组织病（MCTD）：简要报告。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971272403231221103006

Niloofar Shashaani, Mehrnoush Hassas Yeganeh, Reza Sinaei, Shima Salehi, Reza Shiari

引用次数: 0

Liposomes: An Emerging Strategy for the Effective Treatment of Rheumatoid Arthritis. 脂质体：有效治疗类风湿性关节炎的新策略。

IF 1.2

Current rheumatology reviews Pub Date : 2025-01-01 DOI: 10.2174/0115733971284274240215064826

Vani, Priyanka Kriplani, Ashwani Dhingra, Bhawna Chopra, Ajmer Singh Grewal, Geeta Deswal, Rameshwar Dass, Kumar Guarve

{"title":"Liposomes: An Emerging Strategy for the Effective Treatment of Rheumatoid Arthritis.","authors":"Vani, Priyanka Kriplani, Ashwani Dhingra, Bhawna Chopra, Ajmer Singh Grewal, Geeta Deswal, Rameshwar Dass, Kumar Guarve","doi":"10.2174/0115733971284274240215064826","DOIUrl":"10.2174/0115733971284274240215064826","url":null,"abstract":"Background: A Liposomal delivery system is a novel and distinguishing way of organized medicine administration. The advancements in liposomal technology allow for controlled drug distribution to treat rheumatoid arthritis effectively. Liposomes are microscopic lipid-based vesicles that have shown promise in transporting substances, such as superoxide dismutase, hemoglobin, erythrocyte interleukin-2, gamma interferon, and smaller compounds.Objective: Liposomes are biocompatible, nontoxic, biodegradable, non-immunogenic, and flexible, with sizes ranging from 0.025 to 2.5 micrometers. LDS is normally employed to distribute drugs through topical conduits, but fresh investigation has shown that it offers promise for oral, ocular, and parenteral administration. Our major objective is to gather information about liposomes, focusing on their applicability in rheumatoid arthritis treatment.Methods: In the current review, we have tried to cover the preparation techniques, clinical trials, patents, marketed formulations, vesicle types, formulations used to treat rheumatoid arthritis and other ailments, and layered liposomal formulations with improved characteristics.Conclusion: Research has established LDS as a biocompatible, sustainable, non-toxic, adaptable material. Researchers working on LDS technology in rheumatoid arthritis will find this review particularly useful as it may unclutter novel ways for therapeutic intercessions in treating the disease.","PeriodicalId":11188,"journal":{"name":"Current rheumatology reviews","volume":" ","pages":"123-143"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140027675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0